 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
synapse
|
6 terms
|
 |
|
Biological process
|
cell cycle
|
15 terms
|
 |
|
Biochemical function
|
nucleotide binding
|
10 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
272:21381-21387
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of murine/human Ubc9 provides insight into the variability of the ubiquitin-conjugating system.
|
|
H.Tong,
G.Hateboer,
A.Perrakis,
R.Bernards,
T.K.Sixma.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Murine/human ubiquitin-conjugating enzyme Ubc9 is a functional homolog of
Saccharomyces cerevisiae Ubc9 that is essential for the viability of yeast cells
with a specific role in the G2-M transition of the cell cycle. The structure of
recombinant mammalian Ubc9 has been determined from two crystal forms at 2.0 A
resolution. Like Arabidopsis thaliana Ubc1 and S. cerevisiae Ubc4, murine/human
Ubc9 was crystallized as a monomer, suggesting that previously reported hetero-
and homo-interactions among Ubcs may be relatively weak or indirect. Compared
with the known crystal structures of Ubc1 and Ubc4, which regulate different
cellular processes, Ubc9 has a 5-residue insertion that forms a very exposed
tight beta-hairpin and a 2-residue insertion that forms a bulge in a loop close
to the active site. Mammalian Ubc9 also possesses a distinct electrostatic
potential distribution that may provide possible clues to its remarkable ability
to interact with other proteins. The 2-residue insertion and other sequence and
structural heterogeneity observed at the catalytic site suggest that different
Ubcs may utilize catalytic mechanisms of varying efficiency and substrate
specificity.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Schematic representation of the Ubc9 model in the
P2[1] crystal form. Helices are drawn in red and strands are
drawn in green. The side chain atoms of the ubiquitin-accepting
cysteine^ Cys93 are represented as yellow ball-and-sticks. The
first -helix
(residues 1-18) and the four -strands
(residues 25-30, 36-46, 57-63, and 74-77) consist of amino acids
from the N-terminal half^ of the molecule, whereas the three
other -helices
(residues 109-121, 131-139, and 141-154) consist of residues
from the C-terminal half. These secondary structure elements
comprise approximately 50% of the structure (17% -strands and
33% -helices).
This figure^ was prepared using MOLSCRIPT (55).
|
 |
Figure 5.
Fig. 5. Electrostatic potentials mapped onto the surface of
the mammalian Ubc9, Arabidopsis Ubc1, and S. cerevisiae Ubc4
structures. Among the four different orientations, the "right"
view corresponds to the active site cysteine on the right-hand
side of the figure. This view is similar to that of Fig. 3A. The
rest are generated^ by successive rotations of 90° around
the vertical axis. The color spectrum from red to blue
corresponds to changes from negative^ to positive potential (
10 to 10
K[B]T, where K[B] is the Boltzmann constant). This diagram was
produced using GRASP (50).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(1997,
272,
21381-21387)
copyright 1997.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Grünwald,
and
F.Bono
(2011).
Structure of Importin13-Ubc9 complex: nuclear import and release of a key regulator of sumoylation.
|
| |
EMBO J, 30,
427-438.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Wang,
A.M.Taherbhoy,
H.W.Hunt,
S.N.Seyedin,
D.W.Miller,
D.J.Miller,
D.T.Huang,
and
B.A.Schulman
(2010).
Crystal structure of UBA2(ufd)-Ubc9: insights into E1-E2 interactions in Sumo pathways.
|
| |
PLoS One, 5,
e15805.
|
 |
|
|
|
|
 |
B.A.Schulman,
and
J.W.Harper
(2009).
Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways.
|
| |
Nat Rev Mol Cell Biol, 10,
319-331.
|
 |
|
|
|
|
 |
C.Michelle,
P.Vourc'h,
L.Mignon,
and
C.R.Andres
(2009).
What was the set of ubiquitin and ubiquitin-like conjugating enzymes in the eukaryote common ancestor?
|
| |
J Mol Evol, 68,
616-628.
|
 |
|
|
|
|
 |
A.M.Burroughs,
M.Jaffee,
L.M.Iyer,
and
L.Aravind
(2008).
Anatomy of the E2 ligase fold: implications for enzymology and evolution of ubiquitin/Ub-like protein conjugation.
|
| |
J Struct Biol, 162,
205-218.
|
 |
|
|
|
|
 |
P.Knipscheer,
A.Flotho,
H.Klug,
J.V.Olsen,
W.J.van Dijk,
A.Fish,
E.S.Johnson,
M.Mann,
T.K.Sixma,
and
A.Pichler
(2008).
Ubc9 sumoylation regulates SUMO target discrimination.
|
| |
Mol Cell, 31,
371-382.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Z.Tang,
C.M.Hecker,
A.Scheschonka,
and
H.Betz
(2008).
Protein interactions in the sumoylation cascade: lessons from X-ray structures.
|
| |
FEBS J, 275,
3003-3015.
|
 |
|
|
|
|
 |
A.D.Capili,
and
C.D.Lima
(2007).
Structure and analysis of a complex between SUMO and Ubc9 illustrates features of a conserved E2-Ubl interaction.
|
| |
J Mol Biol, 369,
608-618.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Wang,
O.Schueler-Furman,
I.Andre,
N.London,
S.J.Fleishman,
P.Bradley,
B.Qian,
and
D.Baker
(2007).
RosettaDock in CAPRI rounds 6-12.
|
| |
Proteins, 69,
758-763.
|
 |
|
|
|
|
 |
F.J.Kaiser,
H.J.Lüdecke,
and
S.Weger
(2007).
SUMOylation modulates transcriptional repression by TRPS1.
|
| |
Biol Chem, 388,
381-390.
|
 |
|
|
|
|
 |
K.Sakaguchi,
A.Koshiyama,
and
K.Iwabata
(2007).
Meiosis and small ubiquitin-related modifier (SUMO)-conjugating enzyme, Ubc9.
|
| |
FEBS J, 274,
3519-3531.
|
 |
|
|
|
|
 |
K.Wiehe,
B.Pierce,
W.W.Tong,
H.Hwang,
J.Mintseris,
and
Z.Weng
(2007).
The performance of ZDOCK and ZRANK in rounds 6-11 of CAPRI.
|
| |
Proteins, 69,
719-725.
|
 |
|
|
|
|
 |
S.Chaudhury,
A.Sircar,
A.Sivasubramanian,
M.Berrondo,
and
J.J.Gray
(2007).
Incorporating biochemical information and backbone flexibility in RosettaDock for CAPRI rounds 6-12.
|
| |
Proteins, 69,
793-800.
|
 |
|
|
|
|
 |
A.Tomoiu,
A.Gravel,
R.M.Tanguay,
and
L.Flamand
(2006).
Functional interaction between human herpesvirus 6 immediate-early 2 protein and ubiquitin-conjugating enzyme 9 in the absence of sumoylation.
|
| |
J Virol, 80,
10218-10228.
|
 |
|
|
|
|
 |
R.C.van Waardenburg,
D.M.Duda,
C.S.Lancaster,
B.A.Schulman,
and
M.A.Bjornsti
(2006).
Distinct functional domains of Ubc9 dictate cell survival and resistance to genotoxic stress.
|
| |
Mol Cell Biol, 26,
4958-4969.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.T.Huang,
A.Paydar,
M.Zhuang,
M.B.Waddell,
J.M.Holton,
and
B.A.Schulman
(2005).
Structural basis for recruitment of Ubc12 by an E2 binding domain in NEDD8's E1.
|
| |
Mol Cell, 17,
341-350.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Ding,
Y.Yang,
J.Zhang,
J.Wu,
H.Liu,
and
Y.Shi
(2005).
Structural basis for SUMO-E2 interaction revealed by a complex model using docking approach in combination with NMR data.
|
| |
Proteins, 61,
1050-1058.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Saxena,
D.M.Jacobs,
M.Vogtherr,
S.Grimme,
B.Elshort,
B.Pescatore,
M.Betz,
U.Schieborr,
T.Langer,
H.Schwalbe,
and
K.Fiebig
(2005).
Backbone NMR assignment of the human E2 ubiquitin conjugating enzyme UbcH5alpha (F72K,F82S) double mutant.
|
| |
J Biomol NMR, 32,
338.
|
 |
|
|
|
|
 |
M.H.Tatham,
S.Kim,
E.Jaffray,
J.Song,
Y.Chen,
and
R.T.Hay
(2005).
Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
|
| |
Nat Struct Mol Biol, 12,
67-74.
|
 |
|
|
|
|
 |
Y.Y.Mo,
and
S.J.Moschos
(2005).
Targeting Ubc9 for cancer therapy.
|
| |
Expert Opin Ther Targets, 9,
1203-1216.
|
 |
|
|
|
|
 |
A.Pichler,
P.Knipscheer,
H.Saitoh,
T.K.Sixma,
and
F.Melchior
(2004).
The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type.
|
| |
Nat Struct Mol Biol, 11,
984-991.
|
 |
|
|
|
|
 |
C.Dominguez,
A.M.Bonvin,
G.S.Winkler,
F.M.van Schaik,
H.T.Timmers,
and
R.Boelens
(2004).
Structural model of the UbcH5B/CNOT4 complex revealed by combining NMR, mutagenesis, and docking approaches.
|
| |
Structure, 12,
633-644.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.S.Johnson
(2004).
Protein modification by SUMO.
|
| |
Annu Rev Biochem, 73,
355-382.
|
 |
|
|
|
|
 |
N.Nameki,
M.Yoneyama,
S.Koshiba,
N.Tochio,
M.Inoue,
E.Seki,
T.Matsuda,
Y.Tomo,
T.Harada,
K.Saito,
N.Kobayashi,
T.Yabuki,
M.Aoki,
E.Nunokawa,
N.Matsuda,
N.Sakagami,
T.Terada,
M.Shirouzu,
M.Yoshida,
H.Hirota,
T.Osanai,
A.Tanaka,
T.Arakawa,
P.Carninci,
J.Kawai,
Y.Hayashizaki,
K.Kinoshita,
P.Güntert,
T.Kigawa,
and
S.Yokoyama
(2004).
Solution structure of the RWD domain of the mouse GCN2 protein.
|
| |
Protein Sci, 13,
2089-2100.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.J.Winn,
T.L.Religa,
J.N.Battey,
A.Banerjee,
and
R.C.Wade
(2004).
Determinants of functionality in the ubiquitin conjugating enzyme family.
|
| |
Structure, 12,
1563-1574.
|
 |
|
|
|
|
 |
L.N.Kinch,
Y.Qi,
T.J.Hubbard,
and
N.V.Grishin
(2003).
CASP5 target classification.
|
| |
Proteins, 53,
340-351.
|
 |
|
|
|
|
 |
P.Y.Wu,
M.Hanlon,
M.Eddins,
C.Tsui,
R.S.Rogers,
J.P.Jensen,
M.J.Matunis,
A.M.Weissman,
A.M.Weisman,
A.M.Weissman,
C.Wolberger,
C.P.Wolberger,
and
C.M.Pickart
(2003).
A conserved catalytic residue in the ubiquitin-conjugating enzyme family.
|
| |
EMBO J, 22,
5241-5250.
|
 |
|
|
|
|
 |
S.M.Gisler,
S.Pribanic,
D.Bacic,
P.Forrer,
A.Gantenbein,
L.A.Sabourin,
A.Tsuji,
Z.S.Zhao,
E.Manser,
J.Biber,
and
H.Murer
(2003).
PDZK1: I. a major scaffolder in brush borders of proximal tubular cells.
|
| |
Kidney Int, 64,
1733-1745.
|
 |
|
|
|
|
 |
A.P.VanDemark,
and
C.P.Hill
(2002).
SUMO wrestling with specificity.
|
| |
Structure, 10,
281-282.
|
 |
|
|
|
|
 |
D.Jones,
E.Crowe,
T.A.Stevens,
and
E.P.Candido
(2002).
Functional and phylogenetic analysis of the ubiquitylation system in Caenorhabditis elegans: ubiquitin-conjugating enzymes, ubiquitin-activating enzymes, and ubiquitin-like proteins.
|
| |
Genome Biol, 3,
RESEARCH0002.
|
 |
|
|
|
|
 |
O.Pornillos,
S.L.Alam,
R.L.Rich,
D.G.Myszka,
D.R.Davis,
and
W.I.Sundquist
(2002).
Structure and functional interactions of the Tsg101 UEV domain.
|
| |
EMBO J, 21,
2397-2406.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.L.Kurtzman,
and
N.Schechter
(2001).
Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification.
|
| |
Proc Natl Acad Sci U S A, 98,
5602-5607.
|
 |
|
|
|
|
 |
C.M.Pickart
(2001).
Mechanisms underlying ubiquitination.
|
| |
Annu Rev Biochem, 70,
503-533.
|
 |
|
|
|
|
 |
C.Ptak,
C.Gwozd,
J.T.Huzil,
T.J.Gwozd,
G.Garen,
and
M.J.Ellison
(2001).
Creation of a pluripotent ubiquitin-conjugating enzyme.
|
| |
Mol Cell Biol, 21,
6537-6548.
|
 |
|
|
|
|
 |
D.Sleep,
C.Finnis,
A.Turner,
and
L.Evans
(2001).
Yeast 2 microm plasmid copy number is elevated by a mutation in the nuclear gene UBC4.
|
| |
Yeast, 18,
403-421.
|
 |
|
|
|
|
 |
F.Melchior
(2000).
SUMO--nonclassical ubiquitin.
|
| |
Annu Rev Cell Dev Biol, 16,
591-626.
|
 |
|
|
|
|
 |
F.Jiang,
and
R.Basavappa
(1999).
Crystal structure of the cyclin-specific ubiquitin-conjugating enzyme from clam, E2-C, at 2.0 A resolution.
|
| |
Biochemistry, 38,
6471-6478.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Q.Liu,
Y.C.Yuan,
B.Shen,
D.J.Chen,
and
Y.Chen
(1999).
Conformational flexibility of a ubiquitin conjugation enzyme (E2).
|
| |
Biochemistry, 38,
1415-1425.
|
 |
|
|
|
|
 |
S.R.Chakrabarti,
R.Sood,
S.Ganguly,
S.Bohlander,
Z.Shen,
and
G.Nucifora
(1999).
Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9.
|
| |
Proc Natl Acad Sci U S A, 96,
7467-7472.
|
 |
|
|
|
|
 |
S.Y.Cai,
R.W.Babbitt,
and
V.T.Marchesi
(1999).
A mutant deubiquitinating enzyme (Ubp-M) associates with mitotic chromosomes and blocks cell division.
|
| |
Proc Natl Acad Sci U S A, 96,
2828-2833.
|
 |
|
|
|
|
 |
A.Hershko,
and
A.Ciechanover
(1998).
The ubiquitin system.
|
| |
Annu Rev Biochem, 67,
425-479.
|
 |
|
|
|
|
 |
L.D.Mastrandrea,
E.M.Kasperek,
E.G.Niles,
and
C.M.Pickart
(1998).
Core domain mutation (S86Y) selectively inactivates polyubiquitin chain synthesis catalyzed by E2-25K.
|
| |
Biochemistry, 37,
9784-9792.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|